MedPath

Is a Carnitine Based Food Supplement (PorimoreTM) for Infertile Men Superior to Folate and Zinc With Regard to Pregnancy Rates in Intrauterine Insemination Cycles?

Not Applicable
Conditions
Male Infertility
Interventions
Dietary Supplement: Porimore - A Carnitine based food supplement
Dietary Supplement: Zinc and Folate Supplementation
Registration Number
NCT01075334
Lead Sponsor
Shaare Zedek Medical Center
Brief Summary

Many cases of male infertility are poorly understood and regarded as unexplained. Therefore, a etiological treatment for this condition can not be offered in most cases. A beneficial effect on sperm motility was found in trails using antioxidants such as carnitine, zinc and folic acid. However, most studies lacked a sufficient power to detect a significant effect on pregnancy rates. In this study, infertile men with abnormal sperm quality parameters will be randomized to receive either carnitine-based food supplement (Porimore) or folate and Zinc Tablets.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
100
Inclusion Criteria
  • infertility
  • at least one abnormal sperm quality parameter
  • female age < 35
  • normal ovarian reserve
Exclusion Criteria
  • known allergy to one of the food additives planned for treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Porimore armPorimore - A Carnitine based food supplementInfertile men will receive 'Porimore' tablets for a period of time in which three intrauterine insemination cycles will be performed.
Folate and ZincZinc and Folate Supplementation-
Primary Outcome Measures
NameTimeMethod
Pregnancy Rate3 Insemination cycles

proportion of women becoming pregnancy following treatment with intrauterine insemination

Secondary Outcome Measures
NameTimeMethod
Sperm quality parameters3 months

Trial Locations

Locations (1)

Shaare-Zedek IVF and infertility unit

🇮🇱

Jerusalem, Israel

© Copyright 2025. All Rights Reserved by MedPath